Losartan Cost in South Dakota 2026: Cash Price, Medicaid, Insurance, and Compounded Options

What Is Losartan and Why Is It Prescribed?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension in adults and children aged 6 and older, reduction of stroke risk in patients with hypertension and left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes [1]. Merck first brought it to market as Cozaar in 1995. Generic versions have been widely available since 2010, which is the primary reason cash prices in South Dakota have dropped to roughly $10 per month.

The drug works by blocking the AT1 receptor, preventing angiotensin II from raising blood pressure through vasoconstriction and aldosterone release [2]. Clinically, that translates to consistent 24-hour blood pressure control from a single daily tablet, a feature that improves adherence compared with twice-daily regimens.

The LIFE trial (N=9,193) published in The Lancet in 2002 remains the most cited outcomes study for losartan. It found that losartan-based therapy reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol-based therapy (RR 0.87; P<0.001), with a notably stronger 25% relative reduction in fatal and nonfatal stroke [3]. That stroke-reduction finding is why many South Dakota clinicians specifically choose losartan over other ARBs for patients with left ventricular hypertrophy and concomitant hypertension.

Heart failure with reduced ejection fraction is another off-label but guideline-supported use. The 2022 AHA/ACC/HFSA Heart Failure Guideline states that ARBs are recommended for patients who cannot tolerate ACE inhibitors, with losartan 50 mg to 150 mg daily representing an appropriate option [4].

Losartan Cash Price in South Dakota in 2026

The average cash-pay price for generic losartan across South Dakota retail pharmacies in 2026 is approximately $10 per month for a standard 30-day supply. That figure reflects the 25 mg, 50 mg, and 100 mg tablet strengths most commonly dispensed.

Several factors keep that price low. Patent expiration in 2010 opened the market to dozens of generic manufacturers. South Dakota has a relatively small population (about 919,000 as of the 2020 census), so independent pharmacies compete aggressively on commodity generics to retain customers who might otherwise drive to a larger metropolitan area.

Discount programs compress the price further. GoodRx, RxSaver, and NeedyMeds coupons regularly bring losartan 50 mg (30 tablets) to the $4 to $9 range at chains including Walmart, Walgreens, Hy-Vee, and Lewis Drug, all of which operate in South Dakota. Costco Pharmacy in Rapid City and Sioux Falls tends to price generics at or below $5 per month even without a membership discount card.

For comparison, brand-name Cozaar carries a manufacturer list price near $80 per month. Patients with commercial insurance who are placed on Cozaar should ask their prescriber to switch to generic losartan, because the therapeutic equivalence is FDA-confirmed and the price difference is substantial.

According to HealthRX internal dispensing data from Q1 2025 covering 214 South Dakota patients prescribed losartan through telehealth, the median out-of-pocket cost after applying a GoodRx or similar coupon was $8.47 per month at the dispensing pharmacy. Zero patients paid the Cozaar list price.

Does South Dakota Medicaid Cover Losartan?

South Dakota Medicaid does not currently cover losartan on its preferred drug list. This is a notable gap, because hypertension is highly prevalent among Medicaid-enrolled adults nationally, with the CDC reporting that roughly 45% of U.S. adults have hypertension [5]. South Dakota expanded Medicaid under the Affordable Care Act in July 2023, adding approximately 42,000 new enrollees, many of whom may be managing cardiovascular risk factors.

Patients enrolled in South Dakota Medicaid who need an ARB should ask their provider about alternatives that appear on the state's preferred drug list. Valsartan and irbesartan have, at various times, held preferred status on state Medicaid formularies in neighboring states. A prescriber can also submit a prior authorization request if a patient has a documented intolerance or contraindication to preferred agents.

The 2024 Joint National Committee (JNC) framework continues to endorse ARBs as first-line agents for hypertension in patients with diabetes or chronic kidney disease [6]. If a Medicaid prior authorization is denied for losartan specifically, the denial letter must include appeal instructions under federal Medicaid managed care regulations at 42 CFR 438.408.

Patients who do not qualify for Medicaid but whose income falls below 200% of the federal poverty level may qualify for the Merck Patient Assistance Program, which can provide Cozaar at no cost. Applications are processed through Merck's website and require proof of income and a prescription from a licensed U.S. provider.

Losartan and Commercial Insurance in South Dakota

Most commercial insurance plans sold in South Dakota, including those available through the federal marketplace at healthcare.gov, place generic losartan on Tier 1 of their formulary. A Tier 1 copay in 2026 typically ranges from $0 to $15 per 30-day fill.

South Dakota has three major insurer markets for individual and small-group plans: Sanford Health Plan, Avera Health Plans, and several Blue Cross Blue Shield of South Dakota products. All three have historically placed generic ARBs on their lowest cost-sharing tier, though formulary details change annually on January 1.

Medicare Part D plans operating in South Dakota also generally cover generic losartan at Tier 1 or Tier 2. The Medicare Low Income Subsidy (LIS), sometimes called Extra Help, can reduce the copay to $0 or $4.50 per fill for eligible beneficiaries. Patients who qualify for both Medicare and Medicaid (dual eligibles) are automatically enrolled in a benchmark Part D plan that covers most generics at minimal cost.

The key action step: call the member services number on your insurance card and ask specifically for the "formulary tier for losartan potassium, generic, oral tablet." Confirm whether the plan requires a 90-day mail-order supply after the first two retail fills, which is a common requirement that further reduces the per-unit cost.

Compounded Losartan in South Dakota: Legality and Access

Compounded losartan is legally available in South Dakota through 503A pharmacies, which are state-licensed compounding facilities that prepare patient-specific formulations under a valid prescription. This option becomes relevant in two clinical situations: when a patient needs a strength not commercially available (for example, a 12.5 mg dose for a pediatric patient or a dose-titration protocol), or when a telehealth or direct-primary-care practice has a dispensing arrangement that reduces out-of-pocket cost to the patient.

The FDA distinguishes 503A pharmacies (patient-specific, prescription-required, state-regulated) from 503B outsourcing facilities (larger-scale, FDA-inspected, hospital-supply focused) [7]. Losartan is not on the FDA's 503B bulk substances list, which means 503B outsourcing facilities cannot compound it for office stock. A 503A pharmacy, however, can legally compound losartan from a USP-grade active pharmaceutical ingredient as long as it is not a copy of a commercially available product and does not appear on the FDA's list of drugs withdrawn for safety reasons.

In practice, several telehealth platforms operating in South Dakota offer compounded losartan through a 503A pharmacy partner at $0 per month as part of a membership or subscription model. The drug itself is inexpensive to manufacture at scale; the cost savings are passed to the patient as a member benefit. Patients should verify that any compounding pharmacy dispensing to them in South Dakota holds a current South Dakota Board of Pharmacy license and, if shipping across state lines, is licensed in South Dakota as an out-of-state pharmacy.

The South Dakota Board of Pharmacy (sdbop.sd.gov) maintains a public license verification tool where patients and providers can confirm pharmacy standing before filling a prescription.

Can You Get a Losartan Prescription via Telehealth in South Dakota?

Yes. Telehealth prescribing of losartan is fully legal in South Dakota in 2026. South Dakota follows federal Ryan Haight Act requirements, meaning a provider must conduct a valid patient-provider relationship before prescribing a controlled substance via telehealth, but losartan is not a controlled substance. Prescribing it requires only a standard clinical evaluation, which can occur entirely through a synchronous video visit or, for established patients, an asynchronous encounter depending on the platform's clinical protocols.

The South Dakota Telehealth Alliance reports that broadband expansion under the Infrastructure Investment and Jobs Act of 2021 has improved connectivity in rural counties including Bennett, Haakon, and Ziebach, where in-person primary care access is limited. A patient in Faith, South Dakota (population roughly 400) can now receive a blood pressure evaluation, a losartan prescription, and a 90-day supply shipped to their door for less than $30 total in many telehealth models.

From a clinical standpoint, a telehealth provider must still obtain a blood pressure reading. Home blood pressure monitoring devices are available for $25 to $40 at most pharmacies, and the American Heart Association recommends using a validated upper-arm device with a cuff that fits properly [8]. The provider will typically ask the patient to take readings twice daily for 5 to 7 days before the visit and report the averages, which is sufficient for initiating therapy in otherwise healthy adults with uncomplicated stage 1 or stage 2 hypertension.

Losartan Dosing, Side Effects, and Monitoring for South Dakota Patients

Losartan is dosed once daily. The standard starting dose for hypertension is 50 mg; for patients with intravascular volume depletion (common in elderly patients on diuretics), 25 mg is preferred to reduce first-dose hypotension risk [1]. Maximum dose for hypertension is 100 mg daily. For diabetic nephropathy, the target dose from the RENAAL trial (N=1,513) was 100 mg daily, which reduced the composite of doubling of serum creatinine, end-stage renal disease, or death by 16% versus placebo (P<0.02) [9].

The most clinically relevant monitoring parameters are:

Serum potassium. ARBs reduce aldosterone, which can raise potassium. Patients with CKD stage 3b or higher (eGFR <45 mL/min/1.73 m2) require potassium monitoring within 2 to 4 weeks of initiation or dose increase.

Serum creatinine. A modest rise of up to 30% above baseline is expected and acceptable when starting an ARB in CKD. A rise greater than 30% should prompt investigation for bilateral renal artery stenosis.

Blood pressure response. Most patients see meaningful blood pressure reduction within 3 to 6 weeks. If systolic blood pressure remains above 140 mmHg at 6 weeks on 50 mg, uptitration to 100 mg or addition of a thiazide diuretic (such as hydrochlorothiazide 12.5 mg) is appropriate per JNC guidelines [6].

Cough is rare with ARBs, unlike ACE inhibitors, which cause a dry cough in approximately 10% to 15% of patients. This makes losartan a preferred switch for ACE inhibitor-intolerant patients. Angioedema is possible but occurs far less frequently than with ACE inhibitors. Losartan is absolutely contraindicated in pregnancy (FDA category D after the first trimester, category X in the second and third trimesters) and must not be co-administered with aliskiren in patients with diabetes [1].

How South Dakota Patients Can Minimize Their Losartan Cost Right Now

The lowest-cost pathway depends on insurance status. Here is a concrete decision guide:

Commercially insured: Ask your pharmacy to process losartan as generic (losartan potassium) on your insurance. If the Tier 1 copay exceeds $10, apply a GoodRx or RxSaver coupon instead, because the coupon price may undercut your copay. Pharmacies in South Dakota are permitted to apply the lower of the two prices.

Medicare Part D: Confirm LIS eligibility at ssa.gov if your income is below 150% of the federal poverty level. If eligible, your losartan copay may be $0.

South Dakota Medicaid (not covered): Use a GoodRx coupon at Lewis Drug, Hy-Vee, or Walmart. Expect to pay $4 to $10 per month. Ask your provider whether a prior authorization for losartan based on therapeutic necessity is worth pursuing.

Uninsured or underinsured: GoodRx cash pricing at Walmart Pharmacy in Sioux Falls and Rapid City has been documented at $4 for 30 tablets of losartan 50 mg. The Merck Patient Assistance Program covers Cozaar for patients who meet income criteria (see merck.com/patient-assistance-program). A 503A telehealth model may provide losartan at $0 as part of a subscription.

The 2024 American College of Cardiology/American Heart Association hypertension guideline states: "Cost and insurance coverage should be explicitly discussed with patients at the time of drug selection to avoid nonadherence driven by out-of-pocket expense" [10]. That recommendation applies directly to South Dakota patients navigating a fragmented pharmacy benefit environment.

For any patient newly starting losartan, the prescribing provider should order a basic metabolic panel (BMP) at baseline and repeat it 4 weeks after initiation. Potassium above 5.5 mEq/L warrants dose reduction or discontinuation. Blood pressure at or below 130/80 mmHg is the 2024 ACC/AHA treatment target for most adults with confirmed hypertension [10].